Clinical potential of psilocybin as a treatment for mental health conditions
Mental Health Clinician – January 01, 2017
Source: OpenAlex
Summary
Psilocybin, a potent hallucinogen, is revolutionizing Psychiatry's approach to mental health. This chemical, an alkaloid from mushrooms, profoundly influences behavior via Neurotransmitter Receptor Influence, specifically serotonin receptors. Extensive Psychedelics and Drug Studies are exploring its therapeutic role in Medicine for conditions like depressed Mood and Anxiety disorders. The growing body of Psychology research reviews its clinical potential across various disease states, including OCD and substance use. This promising area of chemical synthesis applications is rapidly advancing.
Abstract
Abstract Psilocybin, a classic hallucinogen, is a chemical produced by more than 100 species of mushrooms worldwide. It has high affinity for several serotonin receptors, including 5-HT1A, 5-HT2A, and 5-HT2C, located in numerous areas of the brain, including the cerebral cortex and thalamus. With legislation introduced in 1992, more work is being done to further understand the implications of psilocybin use in a number of disease states. Certain mental health disease states and symptoms have been studied, including depressed mood, anxiety disorders, obsessive-compulsive disorder, alcohol use disorder, and tobacco use disorder. This article provides an in-depth review of the study design and results of psilocybin in each of these conditions and discusses the clinical potential for use.